Table 4.
The related factors of postoperative recurrence.
| Recurrence (n=42) | Non-recurrence (n=170) | χ2 /t | P | |
|---|---|---|---|---|
| Gender [n(%)] | 0.075 | 0.785 | ||
| Male | 21 | 89 | ||
| Female | 21 | 81 | ||
| Average age (years, `x ± s) | 58.07 ± 5.53 | 58.73 ± 5.90 | 0.657 | 0.512 |
| TNM staging [n(%)] | 0.081 | 0.776 | ||
| Stage I | 18 | 77 | ||
| Stage II | 24 | 93 | ||
| Average tumour diameter (cm, `x ± s) | 4.49 ± 0.33 | 4.10 ± 0.30 | 7.394 | <0.001 |
| Operation mode[n(%)] | 1.069 | 0.301 | ||
| Laparotomy | 24 | 82 | ||
| Laparoscopic surgery | 18 | 88 | ||
| The first hepatic portal control [n(%)] | 0.073 | 0.787 | ||
| Yes | 22 | 93 | ||
| No | 20 | 77 | ||
| Child-Pugh grade of liver function [n(%)] | 1.007 | 0.316 | ||
| Grade A | 36 | 134 | ||
| Grade B | 6 | 36 | ||
| Operation time (min,`x ± s) | 222.02 ± 53.44 | 206.65 ± 57.95 | 1.562 | 0.120 |
| Incision length (cm,`x ± s) | 13.19 ± 7.29 | 13.52 ± 7.80 | 0.249 | 0.804 |
| Intraoperative blood loss (ml,`x ± s) | 242.57 ± 63.04 | 245.08 ± 56.73 | 0.251 | 0.802 |
| Microvascular invasion [n(%)] | 24.032 | <0.001 | ||
| Yes | 27 | 41 | ||
| No | 15 | 128 | ||
| Tumour capsular n(%)] | 5.328 | 0.021 | ||
| Yes | 17 | 39 | ||
| No | 25 | 131 | ||
| Portal vein invasion [n(%)] | 5.468 | 0.019 | ||
| Yes | 18 | 42 | ||
| No | 24 | 128 | ||
| Postoperative complications [n(%)] | 3.541 | 0.060 | ||
| Yes | 10 | 21 | ||
| No | 32 | 149 |